Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Kalvin C. Yu"'
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Infections caused by multi-drug resistant Gram-negative pathogens are associated with worse clinical outcomes in critically ill patients. We evaluated hospital outcomes based on adequacy of overall and newer antibacterial therapy
Externí odkaz:
https://doaj.org/article/44c58710241b45c59df79ccc2b4eac64
Publikováno v:
International Journal of Infectious Diseases, Vol 143, Iss , Pp 107023- (2024)
ABSTRACT: Objectives: To evaluate the clinical and economic outcomes in adults hospitalized with invasive pneumococcal disease (IPD) and noninvasive all-cause pneumonia (ACP) overall and by antimicrobial resistance (AMR) status. Methods: Hospitalized
Externí odkaz:
https://doaj.org/article/ff12dbc583b44d919254d0af9d183803
Autor:
Karri A. Bauer, Laura A. Puzniak, Kalvin C. Yu, Kenneth P. Klinker, Janet A. Watts, Pamela A. Moise, Lyn Finelli, Vikas Gupta
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Antibiotic usage and antibiotic resistance (ABR) patterns changed during the COVID-19 pandemic. Inadequate empiric antibiotic therapy (IET) is a significant public health problem and contributes to ABR. We evaluated factors associ
Externí odkaz:
https://doaj.org/article/bd79a4f4ac744a1ab3a466f90d277b7c
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 4 (2024)
Abstract Background: We investigated trends in Staphylococcus aureus (staph) bacteremia incidence stratified by methicillin susceptibility (methicillin-susceptible S. aureus [MSSA] vs. methicillin-resistant S. aureus [MRSA]) and onset designation (c
Externí odkaz:
https://doaj.org/article/64c119726c25467b8191b05c500e80b8
Autor:
Todd Riccobene, ChinEn Ai, Kalvin C. Yu, Sara Gregory, Brooke Kim, Dmitri Debabov, Vikas Gupta
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 6 (2023)
ABSTRACT New antibiotics have been developed to combat antibiotic-resistant Gram-negative pathogens, which are difficult to treat and associated with poor clinical outcomes. We conducted a multicenter evaluation of real-world testing practices and su
Externí odkaz:
https://doaj.org/article/2cf99efcbf7e42658bdb3539d7a6284f
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Excessive use of antibiotics has been reported during the SARS-CoV-2 pandemic. We evaluated trends in antibiotic use and culture positive Gram-negative (GN)/Gram-positive (GP) pathogens in US hospitalized patients before and durin
Externí odkaz:
https://doaj.org/article/dc22b52b6dfd4b6980821c8ba0468179
Autor:
Karri A. Bauer, Laura A. Puzniak, Kalvin C. Yu, Lyn Finelli, Pamela Moise, ChinEn Ai, Janet A. Watts, Vikas Gupta
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Bloodstream infections (BSIs) are an important cause of morbidity and mortality in hospitalized patients. We evaluate incidence of community- and hospital-onset BSI rates and outcomes before and during the SARS-CoV-2 pandemic. Met
Externí odkaz:
https://doaj.org/article/7d707de5abbc43ccaf55dccc20eb8795
Publikováno v:
International Journal of Infectious Diseases, Vol 119, Iss , Pp 142-145 (2022)
[Abstract]: Antimicrobial resistance (AMR) can complicate effective management of urinary tract infections. We conducted a retrospective study of AMR in Enterobacterales urine isolates from ambulatory and hospitalized adult patients from 2018-2020 (B
Externí odkaz:
https://doaj.org/article/8f5156fb92ef4f2884574678552b298d
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Urinary tract infections (UTIs), which are usually caused by bacteria in the Enterobacterales family, are a common reason for outpatient visits. Appropriate empiric therapy for UTIs requires an understanding of antibiotic resistan
Externí odkaz:
https://doaj.org/article/bbad54ff117a43b28da0e0764ff129e7
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 3 (2022)
ABSTRACT Adoption of revised antimicrobial susceptibility breakpoints is often slow, potentially leading to underreporting of antimicrobial resistance. We compared facility-reported rates of carbapenem nonsusceptibility (NS; intermediate or resistant
Externí odkaz:
https://doaj.org/article/281bf487e8474179b06c336396bce513